The use of remifentanil in clinical anesthesia.
Philip
B K
BK
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
D015760:Alfentanil / Q000008:administration & dosage; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use; D000762:Anesthesia Recovery Period; D000765:Anesthesia, Conduction; D000772:Anesthesia, Local; D018685:Anesthetics, Inhalation / Q000008:administration & dosage; D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D007530:Isoflurane / Q000008:administration & dosage; D008657:Metabolic Clearance Rate; D010149:Postoperative Pain / Q000188:drug therapy; D010880:Piperidines / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D015742:Propofol / Q000008:administration & dosage; D011957:Receptors, Opioid / Q000819:agonists; D000077208:Remifentanil; D012119:Respiration / Q000187:drug effects
D000701:Analgesics, Opioid; D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D010880:Piperidines; D011957:Receptors, Opioid; D015760:Alfentanil; D007530:Isoflurane; D000077208:Remifentanil; D015742:Propofol